- A drug combination already used in advanced prostate cancer now appears to significantly…
Blog
-
Drug Combo Therapy Lowers Death Risk by Over 40%
Share on Pinterest A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images -
Mavericks exercise team option on Dereck Lively II
DALLAS – The Dallas Mavericks announced today that they have exercised their fourth-year team option on center Dereck Lively II for the 2026-27 season.
Lively (7-1, 234) earned NBA All-Rookie Second Team honors after his first year, where he…
Continue Reading
-
Google launches Google Maps in Gemini API
Google has launched its Google Maps tool in its artificial intelligence (AI)-powered Gemini API. The move will give developers the ability to use Google Maps’ data to ground their apps.
“This allows…
Continue Reading
-
The 77″ LG Evo C5 4K OLED TV (2025 Model) Drops to Under $2,000 on Amazon
Ahead of the holiday season, Amazon just dropped the price on a current generation LG OLED TV. Right now you can order a massive 77″ LG Evo C5 4K OLED Smart TV for $1,996.99 with free delivery. The 77″ size is rarely discounted to under $2,000…
Continue Reading
-
Breaking down rare earth element magnets for recycling
All the world’s discarded phones, bricked laptops, and other trashed electronics are collectively a treasure trove of rare earth elements (REEs). But separating out and recovering these…
Continue Reading
-
Joe Swash: Forgotten Young Dads review – a shoddy hour of useless television | Documentary
I grew up surrounded by children having children. My all-girls school was known locally as “the pram pushers” – the first person in my cohort to get pregnant was 13; in my sister’s it was an 11-year-old – and my mother worked as a family…
Continue Reading
-
FDA Approves Third-Ever Drug for Lupus Nephritis – Medscape
- FDA Approves Third-Ever Drug for Lupus Nephritis Medscape
- Roche Receives FDA Approval for Kidney Inflammation Drug The Wall Street Journal
- Lupus Research Alliance Applauds U.S. FDA Approval of Gazyva® (Obinutuzumab) for Lupus Nephritis Morningstar
- Roche says FDA approves Gazyva/Gazyvaro for the treatment of lupus nephritis MarketScreener
- Roche’s Gazyva Expands Out of Cancer With FDA Approval for Lupus BioSpace
Continue Reading
-
COVID-19 Vaccines: Navigating the Chaos of Conflicting Guidance – Medscape
- COVID-19 Vaccines: Navigating the Chaos of Conflicting Guidance Medscape
- New US COVID guidance makes getting a shot harder Reuters
- Confused about current vaccine recommendations? Here’s what to know Pittsburgh Post-Gazette
- Prescriptions no…
Continue Reading
-
How this Stanford spinout, with a fresh $14 million, plans to revolutionize health-monitoring biowearables – The Business Journals
- How this Stanford spinout, with a fresh $14 million, plans to revolutionize health-monitoring biowearables The Business Journals
- Exclusive: Adaptyx Biosciences raises $14M for biowearable Axios
- Adaptyx raises $14M to support multi-analyte…
Continue Reading
